Biopharmaceutical researcher Vical (VICL +7%) says it will get a $130M upfront payment from Japan's Astellas Pharma (OTCPK:ALPMY) in a new licensing deal to develop and sell its TransVax vaccine.
Biopharmaceutical researcher Vical (VICL +7%) says it will get a $130M upfront payment from...
Recommended For You
More Trending News
About FRTX Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| FRTX | - | - |
| Fresh Tracks Therapeutics, Inc. | ||